Italy establishes healthcare R&D (research and development) commission:
This article was originally published in Clinica
Executive Summary
Italy has established the national healthcare R&D commission. The ultimate aim of the Commissione nazionale della Ricerca Sanitaria (CNRS) is to provide a practical link between national research activities and regional healthcare delivery policies. It will establish research projects in line with national healthcare priorities, and monitor and analyse peer-reviewed data more widely, with a view to broadcasting the implications that emerge from these, according to the health ministry. As such, its activities should, says the ministry, directly influence the delivery of the national healthcare programme. The commission comprises 30 members, equally representing the central government and the collective of regional healthcare authorities (Conferenza Stato Regioni); it is chaired by health minister Livia Turco.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.